Keywords
Dementia
Parkinsonian Disorders
Multiple Sclerosis
Epidemiological Studies
How to Cite
Abstract
The aim was to characterize the population with neurodegenerative diseases in the region of Guarda. An epidemiological, descriptive, cross-sectional study was carried out of the user population of the Local Health Unit of Guarda, EPE, located in the Central Region of Portugal, with an active diagnosis of neurodegenerative disease, according to the International Classification of Primary Health Care - ICPC-2 : P70 - Dementia, N86 - Multiple Sclerosis - and N87 - Parkinsonism. The data source was the Regional Health Administrations Information System (SIARS), and the sample consisted of 2500 people with neurodegenerative disease. Dementia is the most prevalent of these diseases (62%), followed by Parkinsonism (32%). The proportion of active diagnoses was 1.66%. Most are women (66%), the average age is 79 (± 11.99) years, with a range of 92 years, minimum 19 and maximum 111 years. The characterization of the population with an active diagnosis of neurodegenerative diseases proves to be an important contribution to delineating specific and targeted intervention strategies for the target population and, thus, proceeding with the study of the quality of life of people with neurodegenerative diseases and their families.
References
Fundação Calouste Gulbenkian. Dossier Ciência em Cena: O Cérebro e as Doenças Neurodegenerativas: Lisboa. Fundação Calouste Gulbenkian; 2015 [acesso em 2021, agosto 24]. Disponível em: https://content.gulbenkian.pt/wp-content/uploads/sites/16/2018/04/24100926/Dossie_2015_Neurodegenerativas.pdf
Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third Editions. Multiple Sclerosis Journal. 2020;26(14):1816–1821. Doi: 10.1177/1352458520970841
Magyari M, Sorensen PS. The changing course of multiple sclerosis: Rising incidence, change in geographic distribution, disease course, and prognosis. Curr. Opin. Neurol. 2019 jun;32(3):320-326. Doi: 10.1097/WCO.0000000000000695
Beinhoff U, Tumani H, Brettschneider J, Bitnner D, Riepe, MW. Gender-specificities in Alzheimer's disease and mild cognitive impairment. J Neurol. 2008;255:117–122. Doi: 10.1007/s00415-008-0726-9
Van Den Eeden, SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM. Incidence of parkinson's disease: Variation by age, gender, and race/ethnicity. American Journal of Epidemiology. 2003;157(11):1015-22. Doi: 10.1093/aje/kwg068
Intituto Nacional de Estatística (IP). População residente (n.º) por Local de residência (NUTS - 2013), Sexo e Grupo etário (Por ciclos de vida); Anual - INE, Estimativas anuais da população residente [Internet]. 2020 [atualizada em 2021 jun 14; acesso em 2021 dez 15]; Disponível em: https://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_unid_territorial&menuBOUI=13707095&contexto=ut&selTab=tab3
Instituto Nacional de Estatística (IP). Censos 2021 Resultados Provisórios [Internet]. Lisboa: INE; 2022. [atualizada em 2021 dez 16; acesso em 2022 abril 21]. Disponível em: https://www.ine.pt/scripts/db_censos_2021.html
Pordata. índice de Envelhecimento [Internet]. 2020 [atualizada em 2020 jun 16; acesso em 2022 dez 21. Disponível em: https://www.pordata.pt/Municipios/%C3%8Dndice+de+envelhecimento-458
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann, J. et al. Parkinson disease. Nat Rev Dis Primers. 2017;3(17013). Doi: 10.1038/nrdp.2017.13
Mhyre TR, Boyd J, Hamill RW, Maguire-Zeiss KA. Parkinson's disease. Subcell Biochem. 2012;65:389-455. Doi: 10.1007/978-94-007-5416-4_16
Scorza FA, Carmo AC, Fiorini AC, Nejm MB, Scorza CA, Finsterer J et al. Sudden unexpected death in Parkinson's disease (SUDPAR): a review of publications since the decade of the brain. Clinics. 2017;72(11):649-651. Doi: 10.6061/clinics/2017(11)01
Alzheimer-Europe. Dementia in Europe Yearbook 2019 Estimating the prevalence of dementia in Europe [Internet]. 2019 [acesso em jun 10]. Disponível em: www.alzheimer-europe.org/sites/default/files/alzheimer_europe_dementia_in_europe_yearbook_2019.pdf
Llibre-Guerra JJ, Prina M, Sosa AL, Acosta D, Jimenez-Velazquez IZ, Guerra M et al. Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community-based study. Lancet Regional Health. Americas. 2022;7. Doi: 10.1016/j.lana.2021.100136
Lau LM, Breteler MM. Epidemiology of parkinson's disease. Lancet Neurology. 2006;5(6):525-535. Doi: 10.1016/S1474-4422(06)70471-9
Lee A, Gilbert RM. Epidemiology of parkinson disease. Neurologic Clinics. 2016;34(4):955-965. Doi: 10.1016/j.ncl.2016.06.012
Nussbaum, RL, Ellis CE. Alzheimer's disease and parkinson's disease. New England Journal of Medicine. 2003; 348(14):1356-1364. Doi: 10.1056/NEJM2003ra020003
Coyle PK. What Can We Learn from Sex Differences in MS? Journal of personalized medicine. 2021;11(10):1006. Doi: 10.3390/jpm11101006
Observatório Europeu de Sistemas e Políticas de Saúde (OCDE). Portugal: Perfil de Saúde do País 2019: Bruxelas: Publicação da OCDE, Observatório Paris/Observatório Europeu de Sistemas e Políticas de Saúde. 2019. Doi: 10.1787/75b2eac0-pt
Chêne G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, et al. Gender and incidence of dementia in the framingham heart study from mid-adult life. Alzheimer's and Dementia. 2015;11(3):310-320. Doi: 10.1016/j.jalz.2013.10.005
Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R. Lifetime risk of dementia and alzheimer's disease: The impact of mortality on risk estimates in the framingham study. Neurology. 1997;49(6):1498-1504. Doi: 10.1212/WNL.49.6.1498
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing alzheimer's disease greater for women than for men? American Journal of Epidemiology. 2001;53(2):132-136. Doi: 10.1093/aje/153.2.132
Benito-León J, Bermejo-Pareja F, Rodríguez J, Molina JA, Gabriel R, Morales JM. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2013;18(3):267-274. Doi: 10.1002/mds.10362
Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM et al. Complete ascertainment of Parkinson disease in the Swedish Twin Registry. Neurobiol Aging. 2008;29(12):1765-1773. Doi: 10.1016/j.neurobiolaging.2007.04.009
Murtonen A, Sumelahti M. Multiple sclerosis prevalence in 2000 and 2010 in Western Finland. Acta Neurol. Scand. 2019;141:311–318. Doi: 10.1111/ane.13203
Magyari M, Sorensen PS. The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis. Curr Opin Neurol. 2019;32(3):320-326. Doi: 10.1097/WCO.0000000000000695
Koch-Henriksen N, Thygesen LC, Stenager E, Laursen B, Magyari M. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology. 2018;90(22):1954–1963. Doi: 10.1212/WNL.0000000000005612
Branco M, Alves I, da Silva AM, Pinheiro J, Sá MJ, Correia I, et al. The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study. BMC Neurol. 2020;20(195):2-7. Doi: 10.1186/s12883-020-01755-8
Santana I, Farinha F, Freitas S, Rodrigues V, Carvalho A. Epidemiologia da Demência e da Doença de Alzheimer em Portugal: Estimativas da Prevalência e dos Encargos Financeiros com a Medicação. Acta Médica Portuguesa. 2015;28(2):182-188. Doi: 10.20344/amp.6025
Gonçalves-Pereira M, Cardoso A, Verdelho A, da Silva JA, Almeida MC, Al, Fernandes, C, et al. A prevalência de demência em uma amostra comunitária portuguesa: um estudo do Grupo de Pesquisa de Demência 10/66. BMC Geriatr. 2017;17(261):2-11. Doi: 10.1186/s12877-017-0647-5.pdf
Fernandes I, Filho ASA. Estudo Clínico-Epidemiológico de pacientes com doença de Parkinson em Salvador-Bahia. Revista Brasileira de Neurologia e Psiquiatria. 2018;22(1):45-49.
Baggio BF, Teles RA, Renosto, Alvarenga LFC. Perfil epidemiológico de indivíduos com Esclerose Múltipla de uma associação de referência. Rev Neurocienc [Internet]. 2011 [acesso em 2022 abr 22];19(3):458-461. Disponível em: https://www.revneuropsiq.com.br/rbnp/article/view/244?msclkid=297dd127c29e11ec96d7a9bd74953896
Neves C, Rente J, Ferreira A, Garrett A. Quality of life of people with multiple sclerosis and their caregivers. Revista de Enfermagem Referência. 2017;Serie IV(12):85-96. Doi: 10.12707/RIV16081
Souza LM, Oliveira ES, Sousa NAC, Arêas GPT, Arêas FZS. Perfil epidemiológico e funcional de pacientes com diagnóstico de esclerose múltipla em Manaus, Amazonas. Acta Fisiátr. 2018;25(4):174-178. Doi: 10.11606/issn.2317-0190.v25i4a163863
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME) [Internet]. 2020 [acesso em 2022 abr 22]. Disponível em: https://ghdx.healthdata.org/gbd-results-tool?params=gbd-api-2019-permalink/4007a45309c3b1a7931d372c3f439227
Federação Internacional de Esclerose Múltipla. Estadísticas importantes y datos recopilados del Atlas de EM de MSIF. 2020.
Ferreira JJ, Gonçalves N, Valadas A, Januário C, Silva MR, Nogueira L, et al. Prevalence of Parkinson's disease: a population-based study in Portugal. Eur J Neurol. 2017;24(5):748-750. Doi: 10.1111/ene.13273
Organizatión Mundial de la Salud (OMS). Enfermedad de Parkinson [Internet]. 2022 [acesso em 2022 jul 15]. Disponível em: https://www.who.int/es/news-room/fact-sheets/detail/parkinson-disease
Dorsey ER, Elbaz A, Nichols E, Abbasi N, Abd-Allah F, Abdelalim A, et al. Global Burden of Disease (GBD) 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17:939–953. Doi: 10.1016/S1474-4422(18)30295-3
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Global Academic Nursing Journal